Exact Basilar Artery Occlusion Location Indicates Stroke Etiology and Recanalization Success in Patients Eligible for Endovascular Stroke Treatment
Authors:
- Matthias A. MutkeMMMatthias A. Mutke
- Arne PotreckAPArne Potreck
- Niclas SchmittNSNiclas Schmitt
- Fatih SekerFSFatih Seker
- Peter A. RinglebPRPeter A. Ringleb
- Simon NagelSNSimon Nagel
- Markus A. MöhlenbruchMMMarkus A. Möhlenbruch
- Martin BendszusMBMartin Bendszus
- Charlotte S. WeylandCWCharlotte S. Weyland
- Jessica JesserJJJessica Jesser
Open Access
- 2 December 2022
- journal article
- research article
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 33 (2) , 483-490
Abstract
Introduction: Endovascular stroke treatment (EST) is commonly performed for acute basilar artery occlusion (BAO). We aimed to identify the role of the exact location of BAO in patients receiving EST regarding the stroke etiology, recanalization success and prediction of favorable clinical outcome. Methods: Retrospective analysis of 191 consecutive patients treated for BAO with EST from 01/2013 until 06/2021 in a tertiary stroke center. Groups were defined according to exact location of BAO in I: proximal third, II: middle third, III: distal third and IV: tip of the basilar artery. Univariate and multivariate analyses were performed for BAO location comparing stroke etiology, recanalization result and favorable clinical outcome according to mRS 0–3 90 days after stroke onset. Results: Occlusion sides types I–IV were evenly distributed (37, 36, 60 and 58 patients). Types I and II were more often associated with large artery atherosclerosis (50 vs. 10 patients, p < 0.001). Distal/tip occlusion (types III/IV) occurred mostly in cardiac embolism or embolic stroke of unknown source (89 vs. 12 in types I/II, p < 0.001). Occlusion site correlated with the underlying stroke etiology (AUC [Area under the curve] 0.89, p < 0.0001, OR [odds ratio] for embolism in type IV: 245). Recanalization rates were higher in patients with distal occlusions (type III/IV OR 3.76, CI [95% confidence interval] 1.51–9.53, p = 0.0076). The BAO site is not predicting favorable clinical outcome. Conclusion: The exact basilar artery occlusion site in patients eligible for endovascular stroke treatment reflects the stroke etiology and is associated with differing recanalization success but does not predict favorable clinical outcome.Keywords
Funding Information
- Medizinische Fakultät Heidelberg der Universität Heidelberg
This publication has 17 references indexed in Scilit:
- Thrombectomy in posterior circulation stroke: differences in procedures and outcome compared to anterior circulation stroke in the prospective multicentre REVASK registryEuropean Journal of Neurology, 2018
- Impact of stroke mechanism in acute basilar occlusion with reperfusion therapyAnnals of Clinical and Translational Neurology, 2018
- Acute Basilar Artery Occlusion: Differences in Characteristics and Outcomes after Endovascular Therapy between Patients with and without Underlying Severe Atherosclerotic StenosisAmerican Journal of Neuroradiology, 2017
- Effect of Intracranial Atherosclerotic Disease on Endovascular Treatment for Patients with Acute Vertebrobasilar OcclusionAmerican Journal of Neuroradiology, 2016
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Combined Use of Mechanical Thrombectomy with Angioplasty and Stenting for Acute Basilar Occlusions with Underlying Severe Intracranial Vertebrobasilar Stenosis: Preliminary Experience from a Single Chinese CenterAmerican Journal of Neuroradiology, 2015
- Embolic strokes of undetermined source: the case for a new clinical constructThe Lancet Neurology, 2014
- Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic StrokeStroke, 2013
- Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry studyThe Lancet Neurology, 2009
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993